Targeting mitochondrial dysfunction in neurodegenerative disease: Part II

By Burchell Victoria S   Gandhi Sonia   Deas Emma   Wood Nicholas W   Abramov Andrey Y   Plun-Favreau Hélène  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 497-511

Informa Healthcare

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite

Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 13, Iss. 2, 2015-08 ,pp. : 93-98

Bentham Science Publishers

Access to resources Recommend Favorite

Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?

By Dessolin J.   Schuler M.   Quinart A.   De Giorgi F.   Ghosez L.   Ichas F.  

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1202-1212

Bentham Science Publishers

Access to resources Recommend Favorite